Compare ETSY & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETSY | TFX |
|---|---|---|
| Founded | 2005 | 1943 |
| Country | United States | United States |
| Employees | N/A | 14100 |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 4.6B |
| IPO Year | 2015 | N/A |
| Metric | ETSY | TFX |
|---|---|---|
| Price | $58.23 | $105.72 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 27 | 10 |
| Target Price | $62.55 | ★ $139.67 |
| AVG Volume (30 Days) | ★ 3.0M | 893.4K |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | $2,854,027,000.00 | ★ $3,189,988,000.00 |
| Revenue This Year | $4.80 | $9.60 |
| Revenue Next Year | $2.96 | $10.36 |
| P/E Ratio | $32.56 | ★ N/A |
| Revenue Growth | 1.98 | ★ 5.42 |
| 52 Week Low | $40.05 | $100.18 |
| 52 Week High | $76.52 | $185.94 |
| Indicator | ETSY | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 40.14 |
| Support Level | $59.60 | $102.48 |
| Resistance Level | $64.51 | $107.06 |
| Average True Range (ATR) | 2.24 | 3.37 |
| MACD | -0.32 | -0.46 |
| Stochastic Oscillator | 8.86 | 20.41 |
Etsy operates a top-10 e-commerce marketplace in the US and the UK, with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $12.5 billion in 2024 consolidated gross merchandise volume, Etsy has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. The firm connects about 95 million buyers and 8 million sellers on its marketplace properties: Etsy and Depop (clothing resale).
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.